Evoke Pharma
Evoke Pharma is dedicated to developing treatments for patients living with gastrointestinal diseases, with a focus on unmet medical needs such as diabetic gastroparesis. The company is committed to improving patient lives by providing access to innovative medications, tools, and support during treatment. Their flagship product, GIMOTI, is the first and only FDA-approved nasal spray for diabetic gastroparesis, addressing the limitations of oral medications and supporting patients, especially those on GLP-1 therapies.
Industries
Nr. of Employees
small (1-50)
Evoke Pharma
San Diego, California, United States, North America
Patents
Products
Metoclopramide nasal spray (FDA‑approved non-oral therapy for diabetic gastroparesis)
A nasal spray formulation of metoclopramide designed to bypass the gastrointestinal tract to provide more predictable systemic absorption for relief of symptoms in adults with diabetic gastroparesis.
GIMOTI® (metoclopramide) nasal spray
The first and only FDA-approved non-oral treatment for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis (DGP). It delivers metoclopramide through the nasal route, bypassing the GI tract for more predictable absorption even during flares or vomiting.
Metoclopramide nasal spray (FDA‑approved non-oral therapy for diabetic gastroparesis)
A nasal spray formulation of metoclopramide designed to bypass the gastrointestinal tract to provide more predictable systemic absorption for relief of symptoms in adults with diabetic gastroparesis.
GIMOTI® (metoclopramide) nasal spray
The first and only FDA-approved non-oral treatment for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis (DGP). It delivers metoclopramide through the nasal route, bypassing the GI tract for more predictable absorption even during flares or vomiting.
Services
Partner-managed services for sales, marketing, access and reimbursement, adherence support, and product distribution to execute commercial strategy.
Provision of medical information contacts and distribution of prescribing information and medication guides to support patients and healthcare professionals.
Assessment and acquisition or in-licensing of drug products and candidates, prioritizing compounds with clinical data, IP exclusivity, and gastroenterology relevance.
Partner-managed services for sales, marketing, access and reimbursement, adherence support, and product distribution to execute commercial strategy.
Provision of medical information contacts and distribution of prescribing information and medication guides to support patients and healthcare professionals.
Assessment and acquisition or in-licensing of drug products and candidates, prioritizing compounds with clinical data, IP exclusivity, and gastroenterology relevance.
Expertise Areas
- Diabetic gastroparesis therapeutics
- Clinical trial management for gastroenterology
- Nasal and non-oral drug delivery reformulation
- Regulatory strategy and FDA approval pathways
Key Technologies
- Nasal drug delivery
- Non-oral drug delivery systems
- Small-molecule reformulation
- Clinical trial management